The Real Cost of a Weak IME: Why Cutting Corners Backfires
When evaluating IME providers, cost per examination is often the deciding factor. But the cheapest IME is rarely the least expensive option once you account for what happens when a poorly supported opinion collapses in litigation. A weak IME doesn't just fail to help your case—it can actively make things worse.
What a "Weak" IME Actually Costs
Denied treatment gets reinstated—with penalties. If a treatment denial based on a thin IME opinion is successfully appealed, carriers may be required to authorize the original treatment plus additional therapy to address the delay, along with potential penalties for wrongful denial in some jurisdictions.
Litigation costs increase. A vulnerable report that falls apart in deposition often leads to protracted litigation rather than early resolution—driving up defense costs, expert fees for a second opinion, and the time value of an unresolved claim sitting on the books longer than necessary.
Settlement leverage shifts to the claimant. Once an IME opinion has been discredited, it undermines the carrier's negotiating position for the remainder of the claim, sometimes requiring a settlement premium to resolve a case that could have closed earlier and cheaper.
Reputational cost compounds over time. Examiners known for weak, easily-challenged reports become a liability across your entire caseload, not just the case where the problem surfaced. Plaintiff's attorneys track which examiners are vulnerable and adjust their litigation strategy accordingly.
A Cautionary Pattern
A common scenario: a carrier selects an IME provider based primarily on the lowest fee and fastest turnaround. The resulting report contains boilerplate causation language, doesn't address the treating physician's specific findings, and is based on an examination lasting a fraction of the time comparable evaluations typically require.
At deposition, the examiner cannot adequately explain the reasoning behind key conclusions. The treating physician's opinion is left unchallenged. The claim, which might have settled for a moderate amount with a defensible IME early on, proceeds to litigation and ultimately resolves for significantly more—after accumulating additional defense costs, expert fees, and lost time.
What Quality Actually Buys You
Investing in a thorough, defensible IME upfront provides:
Leverage in early settlement negotiations, because a well-supported opinion signals to opposing counsel that the case is not an easy target
Reduced likelihood of successful appeal on treatment denials or benefit modifications
Consistency across your caseload, since a reliable examiner produces work product that holds up regardless of which case or jurisdiction it's used in
Fewer surprises at deposition, because the reasoning was sound from the start
Evaluating the True Cost-Benefit
When comparing IME providers, consider the full picture:

The upfront savings on a lower-cost IME rarely offset the downstream costs of a report that can't withstand scrutiny.
About Romanelli Orthopedic Forensics (RIME)
Dr. Daniel Romanelli provides thorough, well-reasoned IME evaluations designed to hold up through appeal, deposition, and trial—helping carriers avoid the downstream costs of an inadequate initial evaluation.
Contact Dr. Romanelli today.




Comments